Lionel D Edwards MB, BS, LRCP, MRCS, DipRCOG, FFPM, isSenior Director of Medical Affairs for Novartis USA, and Presidentof Pharma Pro Plus Inc., a drug development consulting company. Dr.Edwards has been involved in all aspects of clinical trials forover 33 years on many different research drug and devices in 10therapeutic areas. Dr. Edwards is a Fellow of the Faculty ofPharmaceutical Medicine and an Adjunct Professor at TempleUniversity Graduate School of Pharmacology. He has taught for thePharmaceutical Education & Research Institute for over 12 yearsand was on the teaching faculty of the National Association ofPhysicians. He is a founder member of the American Academy ofPharmaceutical Physicians.
Anthony W Fox BSc, MBBS, FFPM, FRCP, MD(Lond),DipPharmMedRCP, CBiol, FIBiol, FRSA is President of EBD Group, aconsultancy with offices in San Diego and Munich. Tony is aliveryman guardant of the Worshipful Society of Apothecariesof London. He is an Adjunct (i.e., honorary) Associate ClinicalProfessor in the Skaggs School of Pharmacy and PharmaceuticalSciences, at the University of California, San Diego. Hispublications span several areas of pharmaceutical medicine, e.g.regulation, pharmacology, clinical trials, pharmacovigilance,analgesics, migraine, genotoxicology, and metabolism, and he isnamed as inventor on several patents. He is on the editorial boardsof several journals, and serves in a more senior capacity for twoof them.
Peter D Stonier BA, BSc, PhD, MBChB, MRCPsych, FRCP,FRCPE, FFPM has 29 years experience in pharmaceutical medicine.Peter is Director of Education and Training of the Faculty ofPharmaceutical Medicine, Royal Colleges of Physicians of the UK. Heis Medical Director of Amdipharm Plc, and of Medical ResourceProvider Axess Ltd, and Visiting Professor in pharmaceuticalmedicine at the University of Surrey, which under his directionintroduced the first MSc degree in Pharmaceutical Medicine in 1993,which is now part of the Postgraduate Medical School of theUniversity. His publications include edited works in humanpsychopharmacology, pharmaceutical medicine, clinical research,medical marketing, and careers in the pharmaceutical industry. Heis a member of the Association of Pharmaceutical Physicians andInvestigators (APPI). Professor Stonier has been elected a Fellowof the Royal Society for the encouragement of Arts, Manufacturesand Commerce.